Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 415.99 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 09:20PM GMT
Release Date Price: $9.84 (-2.09%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

Hi, everyone. It's my pleasure to welcome Esperion to the 2021 Credit Suisse Healthcare Conference. We have Sheldon and Joanne joining us. And let me just remind everybody that if you'd like to ask them any questions, you can e-mail me [email protected], and I'll ask those on your behalf. So we do have a long list, and we'll jump right in here.

Questions & Answers

Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

So we thought we could start with just an introduction of bempedoic acid to people who are less familiar with its mechanism and where it fits within the treatment paradigm?

Joanne Micale Foody
Esperion Therapeutics, Inc. - Chief Medical Officer

So Judah, thank you so much for the question. And I'll try to review, as you said, a little bit about bempedoic acid, its mechanism and ultimately, where it fits in the current label.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot